| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | purmorphamine | CTRPv2 | pan-cancer | AAC | 0.0023 | 1 |
| mRNA | Vandetanib | CCLE | pan-cancer | AAC | 0.0028 | 1 |
| mRNA | AA-COCF3 | CTRPv2 | pan-cancer | AAC | 0.0021 | 1 |
| mRNA | BEC | CTRPv2 | pan-cancer | AAC | 0.0043 | 1 |
| mRNA | CIL55 | CTRPv2 | pan-cancer | AAC | -0.0033 | 1 |
| mRNA | myriocin | CTRPv2 | pan-cancer | AAC | -0.0043 | 1 |
| mRNA | BRD-K66532283 | CTRPv2 | pan-cancer | AAC | 0.0018 | 1 |
| mRNA | BIX-01294 | CTRPv2 | pan-cancer | AAC | 0.0018 | 1 |
| mRNA | Sunitinib | CTRPv2 | pan-cancer | AAC | -0.0016 | 1 |
| mRNA | BRD8899 | CTRPv2 | pan-cancer | AAC | 0.0017 | 1 |